Coldstream Capital Management Inc. Invests $205,000 in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Coldstream Capital Management Inc. acquired a new position in Prestige Consumer Healthcare Inc. (NYSE:PBH) during the 3rd quarter, HoldingsChannel reports. The fund acquired 2,783 shares of the company’s stock, valued at approximately $205,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Lombard Odier Asset Management USA Corp acquired a new position in Prestige Consumer Healthcare during the 2nd quarter worth about $550,000. Sequoia Financial Advisors LLC raised its position in shares of Prestige Consumer Healthcare by 12.9% during the third quarter. Sequoia Financial Advisors LLC now owns 9,824 shares of the company’s stock worth $708,000 after acquiring an additional 1,120 shares during the last quarter. Pinnacle Associates Ltd. lifted its stake in shares of Prestige Consumer Healthcare by 60.3% in the third quarter. Pinnacle Associates Ltd. now owns 24,630 shares of the company’s stock worth $1,776,000 after acquiring an additional 9,269 shares during the period. Ariel Investments LLC boosted its holdings in Prestige Consumer Healthcare by 10.7% in the second quarter. Ariel Investments LLC now owns 2,835,203 shares of the company’s stock valued at $195,204,000 after acquiring an additional 274,212 shares during the last quarter. Finally, Citigroup Inc. increased its position in Prestige Consumer Healthcare by 66.6% during the 3rd quarter. Citigroup Inc. now owns 76,772 shares of the company’s stock valued at $5,535,000 after purchasing an additional 30,677 shares during the period. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Stock Performance

NYSE:PBH opened at $80.39 on Wednesday. The firm has a market capitalization of $3.97 billion, a P/E ratio of 19.56, a P/E/G ratio of 2.32 and a beta of 0.49. Prestige Consumer Healthcare Inc. has a twelve month low of $57.95 and a twelve month high of $86.36. The company has a fifty day moving average of $78.65 and a 200-day moving average of $72.86. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, meeting the consensus estimate of $1.09. The firm had revenue of $283.79 million for the quarter, compared to analyst estimates of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The business’s quarterly revenue was down .9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.07 earnings per share. As a group, sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.44 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on PBH shares. StockNews.com downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, December 10th. Jefferies Financial Group restated a “hold” rating and issued a $76.00 target price (up previously from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson reaffirmed a “buy” rating and set a $95.00 price target on shares of Prestige Consumer Healthcare in a research report on Monday, November 11th. Finally, Sidoti lowered Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective for the company. in a research report on Monday, December 9th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $85.25.

Insiders Place Their Bets

In other news, EVP Adel Mekhail sold 9,063 shares of the company’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $82.00, for a total transaction of $743,166.00. Following the transaction, the executive vice president now directly owns 18,365 shares of the company’s stock, valued at $1,505,930. This represents a 33.04 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Mary Beth Fritz sold 9,885 shares of the stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $81.97, for a total value of $810,273.45. Following the completion of the transaction, the senior vice president now owns 18,835 shares in the company, valued at approximately $1,543,904.95. This represents a 34.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 38,810 shares of company stock worth $3,187,300. Corporate insiders own 1.60% of the company’s stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.